3EKP - Sequence, Chains, Asymmetric and Biological Units

• Title: CRYSTAL STRUCTURE OF THE INHIBITOR AMPRENAVIR (APV) IN COMPL MULTI-DRUG RESISTANT HIV-1 PROTEASE VARIANT (L10I/G48V/I54V/V64I/V82A)REFER: FLAP+ IN CITATION
• Keywords: HIV-1, PROTEASE, MULTI-DRUG RESISTANCE, AMPRENAVIR, AIDS, HY
• Experiment: X-ray diffraction
• Number of Models: 1

Database	ID code	Status	Coordinate files
			Header	Asymmetric unit	Biological unit
PDB	3EKP	released	available	available	Quaternary Structure Server

Asymmetric unit from PDB

Unit	Type	Name	Chain ID	Residues	Atoms	Hetatoms
1	Protein	PROTEASE	A	99	736	0
2	Protein	PROTEASE	B	99	743	0
3	Protein	PROTEASE	C	99	738	0
4	Protein	PROTEASE	D	99	743	0
5	Ligand	PROTEASE	A	4	0	17
6	Ligand	PROTEASE	B	7	0	62
7	Ligand	PROTEASE	C	5	0	51
8	Ligand	PROTEASE	D	2	0	8
9	Water			262	0	262
total				676	2960	400

Proteins

Unit 1	PRO 1 GLN 2 ILE 3 THR 4 LEU 5 TRP 6 LYS 7 ARG 8 PRO 9 ILE 10 VAL 11 THR 12 ILE 13 ARG 14 ILE 15 GLY 16 GLY 17 GLN 18 LEU 19 LYS 20 GLU 21 ALA 22 LEU 23 LEU 24 ASP 25 THR 26 GLY 27 ALA 28 ASP 29 ASP 30 THR 31 VAL 32 LEU 33 GLU 34 GLU 35 MET 36 ASN 37 LEU 38 PRO 39 GLY 40 LYS 41 TRP 42 LYS 43 PRO 44 LYS 45 MET 46 ILE 47 VAL 48 GLY 49 ILE 50 GLY 51 GLY 52 PHE 53 VAL 54 LYS 55 VAL 56 ARG 57 GLN 58 TYR 59 ASP 60 GLN 61 ILE 62 PRO 63 ILE 64 GLU 65 ILE 66 CYS 67 GLY 68 HIS 69 LYS 70 ALA 71 ILE 72 GLY 73 THR 74 VAL 75 LEU 76 VAL 77 GLY 78 PRO 79 THR 80 PRO 81 ALA 82 ASN 83 ILE 84 ILE 85 GLY 86 ARG 87 ASN 88 LEU 89 LEU 90 THR 91 GLN 92 ILE 93 GLY 94 CYS 95 THR 96 LEU 97 ASN 98 PHE 99
Unit 2	PRO 1 GLN 2 ILE 3 THR 4 LEU 5 TRP 6 LYS 7 ARG 8 PRO 9 ILE 10 VAL 11 THR 12 ILE 13 ARG 14 ILE 15 GLY 16 GLY 17 GLN 18 LEU 19 LYS 20 GLU 21 ALA 22 LEU 23 LEU 24 ASP 25 THR 26 GLY 27 ALA 28 ASP 29 ASP 30 THR 31 VAL 32 LEU 33 GLU 34 GLU 35 MET 36 ASN 37 LEU 38 PRO 39 GLY 40 LYS 41 TRP 42 LYS 43 PRO 44 LYS 45 MET 46 ILE 47 VAL 48 GLY 49 ILE 50 GLY 51 GLY 52 PHE 53 VAL 54 LYS 55 VAL 56 ARG 57 GLN 58 TYR 59 ASP 60 GLN 61 ILE 62 PRO 63 ILE 64 GLU 65 ILE 66 CYS 67 GLY 68 HIS 69 LYS 70 ALA 71 ILE 72 GLY 73 THR 74 VAL 75 LEU 76 VAL 77 GLY 78 PRO 79 THR 80 PRO 81 ALA 82 ASN 83 ILE 84 ILE 85 GLY 86 ARG 87 ASN 88 LEU 89 LEU 90 THR 91 GLN 92 ILE 93 GLY 94 CYS 95 THR 96 LEU 97 ASN 98 PHE 99
Unit 3	PRO 1 GLN 2 ILE 3 THR 4 LEU 5 TRP 6 LYS 7 ARG 8 PRO 9 ILE 10 VAL 11 THR 12 ILE 13 ARG 14 ILE 15 GLY 16 GLY 17 GLN 18 LEU 19 LYS 20 GLU 21 ALA 22 LEU 23 LEU 24 ASP 25 THR 26 GLY 27 ALA 28 ASP 29 ASP 30 THR 31 VAL 32 LEU 33 GLU 34 GLU 35 MET 36 ASN 37 LEU 38 PRO 39 GLY 40 LYS 41 TRP 42 LYS 43 PRO 44 LYS 45 MET 46 ILE 47 VAL 48 GLY 49 ILE 50 GLY 51 GLY 52 PHE 53 VAL 54 LYS 55 VAL 56 ARG 57 GLN 58 TYR 59 ASP 60 GLN 61 ILE 62 PRO 63 ILE 64 GLU 65 ILE 66 CYS 67 GLY 68 HIS 69 LYS 70 ALA 71 ILE 72 GLY 73 THR 74 VAL 75 LEU 76 VAL 77 GLY 78 PRO 79 THR 80 PRO 81 ALA 82 ASN 83 ILE 84 ILE 85 GLY 86 ARG 87 ASN 88 LEU 89 LEU 90 THR 91 GLN 92 ILE 93 GLY 94 CYS 95 THR 96 LEU 97 ASN 98 PHE 99
Unit 4	PRO 1 GLN 2 ILE 3 THR 4 LEU 5 TRP 6 LYS 7 ARG 8 PRO 9 ILE 10 VAL 11 THR 12 ILE 13 ARG 14 ILE 15 GLY 16 GLY 17 GLN 18 LEU 19 LYS 20 GLU 21 ALA 22 LEU 23 LEU 24 ASP 25 THR 26 GLY 27 ALA 28 ASP 29 ASP 30 THR 31 VAL 32 LEU 33 GLU 34 GLU 35 MET 36 ASN 37 LEU 38 PRO 39 GLY 40 LYS 41 TRP 42 LYS 43 PRO 44 LYS 45 MET 46 ILE 47 VAL 48 GLY 49 ILE 50 GLY 51 GLY 52 PHE 53 VAL 54 LYS 55 VAL 56 ARG 57 GLN 58 TYR 59 ASP 60 GLN 61 ILE 62 PRO 63 ILE 64 GLU 65 ILE 66 CYS 67 GLY 68 HIS 69 LYS 70 ALA 71 ILE 72 GLY 73 THR 74 VAL 75 LEU 76 VAL 77 GLY 78 PRO 79 THR 80 PRO 81 ALA 82 ASN 83 ILE 84 ILE 85 GLY 86 ARG 87 ASN 88 LEU 89 LEU 90 THR 91 GLN 92 ILE 93 GLY 94 CYS 95 THR 96 LEU 97 ASN 98 PHE 99

Ligands

Unit 5	PO4 501 ACT 601 ACT 602 ACT 603
Unit 6	478 200 PO4 502 PO4 503 PO4 505 ACT 604 ACT 605 ACT 606
Unit 7	478 200 ACT 601 ACT 603 ACT 604 ACT 605
Unit 8	ACT 602 ACT 606